Drug:
Reaction: DEVICE MALFUNCTION
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26841268 |
US |
1 | |
Cough, Diarrhoea, Dyspnoea, Therapy non-responder, Device connection issue, Device malfunction, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TESTOSTERONE, NERANDOMILAST, ROSUVASTATIN CALCIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MELATONIN, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, OXYGEN, 0XYGEN, RIVAROXABAN, CLOPIDOGREL, IPRATROPIUM BROMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 702 | 26841489 |
US |
||
Product use complaint, Device malfunction, Product leakage, Pain, Product dose omission issue, Device issue, |
||||
GUSELKUMAB, |
||||
| 703 | 26841996 |
US |
63 | |
Drug delivery system malfunction, Drug dose omission by device, Intentional product use issue, Device malfunction, Product supply issue, Product dose omission issue, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 704 | 26842182 |
US |
55 | |
Urinary tract infection, Device malfunction, Exposure via skin contact, Accidental exposure to product, Intentional dose omission, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 705 | 26842259 |
US |
44 | |
Accidental exposure to product, Exposure via skin contact, Device malfunction, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 706 | 26842289 |
US |
2 | |
Cough, Multiple allergies, Inappropriate schedule of product administration, Device delivery system issue, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 707 | 26842381 |
US |
74 | 2 |
Injection site pain, Device malfunction, |
||||
| 708 | 26842473 |
US |
53 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 709 | 26842885 |
US |
||
Device malfunction, Incorrect dose administered, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 710 | 26842900 |
US |
72 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, Incorrect dose administered by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 711 | 26842918 |
US |
||
Drug dose omission by device, Device malfunction, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 712 | 26842951 |
US |
67 | |
Device malfunction, Incorrect dose administered, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 713 | 26842980 |
US |
69 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, GABAPENTIN, |
||||
| 714 | 26843129 |
US |
54 | 2 |
Device operational issue, Incorrect dose administered by device, Device malfunction, Incorrect dose administered, |
||||
ABATACEPT, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ENALAPRIL, ROSUVASTATIN, |
||||
| 715 | 26843436 |
US |
76 | 1 |
Device malfunction, Product cleaning inadequate, Product dose omission issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 716 | 26843438 |
US |
2 | |
Administration site pain, Application site haemorrhage, Device malfunction, Device delivery system issue, Product dose omission issue, |
||||
SUMATRIPTAN SUCCINATE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROPINIROLE, |
||||
| 717 | 26843481 |
US |
69 | |
Device malfunction, Accidental exposure to product, Product dose omission issue, Off label use, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 718 | 26844010 |
US |
86 | 1 |
Hypoacusis, Product dose omission issue, Device malfunction, Inappropriate schedule of product administration, Needle issue, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 719 | 26844835 |
US |
77 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, AMLODIPINE, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, |
||||
| 720 | 26844839 |
US |
57 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 721 | 26844841 |
US |
79 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 722 | 26844842 |
US |
57 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 723 | 26844844 |
US |
74 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 724 | 26844845 |
US |
65 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 725 | 26844849 |
US |
66 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 726 | 26844855 |
US |
42 | |
Device malfunction, Needle issue, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 727 | 26844857 |
US |
43 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 728 | 26844869 |
US |
74 | |
Accidental exposure to product, Exposure via skin contact, Device malfunction, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 729 | 26844870 |
US |
57 | |
Device malfunction, Exposure via skin contact, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 730 | 26844872 |
US |
70 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, Wrong technique in product usage process, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 731 | 26844877 |
US |
63 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 732 | 26844878 |
US |
||
Product leakage, Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 733 | 26844880 |
US |
49 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 734 | 26844911 |
US |
79 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, Drug dose omission by device, Suspected off label use, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 735 | 26844912 |
US |
70 | |
Device malfunction, Drug dose omission by device, Suspected off label use, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 736 | 26844925 |
US |
37 | |
Device malfunction, Product preparation issue, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 737 | 26834604 |
US |
24 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 738 | 26834692 |
GB |
58 | |
Device malfunction, Injection site haemorrhage, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CELECOXIB, |
||||
| 739 | 26834870 |
US |
36 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 740 | 26834915 |
US |
||
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 741 | 26835045 |
US |
80 | |
Pain, Gait disturbance, Pain in extremity, Oedema peripheral, Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 742 | 26835090 |
US |
45 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 743 | 26835109 |
US |
37 | |
Device malfunction, Device leakage, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 744 | 26835254 |
US |
37 | |
Accidental exposure to product, Exposure via skin contact, Device malfunction, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 745 | 26835271 |
US |
45 | |
Device malfunction, Device leakage, Injection site pain, Needle track marks, |
||||
| 746 | 26835328 |
US |
28 | |
Device malfunction, Anxiety, Accidental exposure to product, Exposure via skin contact, Wrong technique in product usage process, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 747 | 26835404 |
US |
64 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 748 | 26835519 |
US |
12 | |
Device malfunction, Incorrect dose administered, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 749 | 26835602 |
US |
72 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 750 | 26835995 |
US |
2 | |
Device malfunction, Drug dose omission by device, |
||||
GUSELKUMAB, |
||||
| 751 | 26836000 |
US |
73 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 752 | 26836007 |
US |
78 | 2 |
Device delivery system issue, Device malfunction, Product use issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 753 | 26836189 |
US |
||
Increased appetite, Device malfunction, Accidental exposure to product, |
||||
| 754 | 26836372 |
US |
46 | 2 |
Hunger, Device malfunction, Incorrect dose administered by device, |
||||
| 755 | 26836484 |
US |
||
Device malfunction, Device malfunction, Injury associated with device, Injury associated with device, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 756 | 26836735 |
US |
59 | |
Device malfunction, Wrong technique in product usage process, Exposure via skin contact, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 757 | 26836769 |
US |
80 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FUROSEMIDE, |
||||
| 758 | 26836861 |
US |
16 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 759 | 26836892 |
US |
17 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 760 | 26836913 |
US |
1 | |
Dementia, Rehabilitation therapy, Wrong technique in product usage process, Device use issue, Drug dose omission by device, Device malfunction, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 761 | 26836926 |
US |
31 | |
General symptom, Device malfunction, Exposure via skin contact, Accidental exposure to product, Incorrect dose administered by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 762 | 26836932 |
US |
54 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 763 | 26836964 |
US |
1 | |
Hypoacusis, Throat irritation, Device effect decreased, Device malfunction, Device defective, Incorrect dose administered, Wrong technique in product usage process performed in error, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 764 | 26837005 |
US |
2 | |
Drug dose omission by device, Needle issue, Device malfunction, Device leakage, Device use error, |
||||
SECUKINUMAB, |
||||
| 765 | 26837022 |
US |
64 | |
Off label use, Wrong technique in product usage process, Device malfunction, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 766 | 26837030 |
US |
35 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 767 | 26837052 |
US |
32 | 2 |
Drug dose omission by device, Device leakage, Device malfunction, |
||||
| 768 | 26837064 |
US |
2 | |
Product dose omission issue, Device malfunction, Device leakage, |
||||
| 769 | 26837112 |
US |
79 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, Incorrect dose administered by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 770 | 26837121 |
US |
||
Drug dose omission by device, Device malfunction, Incorrect dose administered, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, |
||||
| 771 | 26837122 |
US |
72 | |
Device malfunction, Exposure via skin contact, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 772 | 26837179 |
US |
56 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, HYDROXYCHLOROQUINE, |
||||
| 773 | 26837296 |
US |
66 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 774 | 26837337 |
US |
1 | |
Device malfunction, |
||||
PEGFILGRASTIM, |
||||
| 775 | 26837379 |
US |
70 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 776 | 26837441 |
58 | 1 | |
Fall, Toxicity to various agents, Toxicity to various agents, Seizure, Loss of consciousness, Somnolence, Device issue, Hypothermia, Dizziness, Withdrawal syndrome, Device malfunction, |
||||
BACLOFEN, BACLOFEN, |
||||
| 777 | 26837491 |
US |
48 | 2 |
Drug dose omission by device, Device failure, Device issue, Device malfunction, Device mechanical issue, No adverse event, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, |
||||
| 778 | 26837589 |
US |
25 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 779 | 26837779 |
US |
18 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 780 | 26837796 |
US |
12 | 2 |
Drug dose omission by device, Device malfunction, Device leakage, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 781 | 26837804 |
AR |
54 | 2 |
Device malfunction, Device delivery system issue, Device physical property issue, Drug dose omission by device, Incorrect route of product administration, |
||||
ETANERCEPT, |
||||
| 782 | 26837836 |
CA |
||
Device malfunction, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 783 | 26837874 |
US |
63 | |
Device malfunction, Injection site haemorrhage, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 784 | 26837900 |
US |
19 | |
Device malfunction, Drug dose omission by device, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 785 | 26837932 |
US |
80 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 786 | 26837999 |
US |
||
Device malfunction, Off label use, |
||||
LONAPEGSOMATROPIN-TCGD, |
||||
| 787 | 26838050 |
US |
1 | |
Fatigue, Visual impairment, Pulmonary function test, Intentional product misuse, Device use error, Device malfunction, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 788 | 26830495 |
US |
2 | |
Incorrect dose administered by product, Device malfunction, |
||||
SOMATROPIN, |
||||
| 789 | 26830701 |
US |
2 | |
Device malfunction, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 790 | 26830741 |
US |
||
No adverse event, Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 791 | 26830891 |
US |
72 | 2 |
Injection site pain, Injection site bruising, Air in device issue, Product use in unapproved indication, Injection site discharge, Increased appetite, Device leakage, Device malfunction, Urticaria, Product dose omission issue, |
||||
| 792 | 26830950 |
US |
||
No adverse event, Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 793 | 26831043 |
US |
61 | 2 |
Incorrect dose administered, Accidental exposure to product, Device malfunction, |
||||
GUSELKUMAB, |
||||
| 794 | 26831172 |
US |
||
No adverse event, Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 795 | 26831191 |
US |
66 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 796 | 26831306 |
US |
58 | |
Device malfunction, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 797 | 26831343 |
US |
67 | 2 |
Device malfunction, Injection site haemorrhage, Incorrect dose administered by device, Increased appetite, Drug effect less than expected, Injection site bruising, |
||||
| 798 | 26831446 |
US |
64 | |
Device malfunction, Wrong technique in product usage process performed in error, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALPRAZOLAM, |
||||
| 799 | 26831533 |
US |
2 | |
Device malfunction, Dyspnoea, Incorrect dose administered, |
||||
| 800 | 26831610 |
US |
55 | 2 |
Device malfunction, Product dose omission issue, |
||||
SECUKINUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30